Financial News
Latest News about DYN
Recent news which mentions DYN
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
September 03, 2024
From Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
From Benzinga
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
September 03, 2024
From Benzinga
Nasdaq Dips Over 2%; US Construction Spending Falls In July
September 03, 2024
From Benzinga
Dow Tumbles 1%; ISM Manufacturing PMI Misses Estimates
September 03, 2024
From Benzinga
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 03, 2024
From Benzinga
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
August 13, 2024
From Benzinga
DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024
August 12, 2024
Tickers
DYN
From InvestorPlace
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
July 14, 2024
From Benzinga
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
June 12, 2024
From Benzinga
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
June 12, 2024
From Benzinga
From InvestorPlace
From Benzinga
Why Is Dyne Therapeutics Stock Soaring On Monday?
May 20, 2024
From Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
From Benzinga
From InvestorPlace
Tickers
DYN
From InvestorPlace
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
From Benzinga
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
March 25, 2024
From Benzinga
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
March 14, 2024
From Benzinga
Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know
March 08, 2024
Tickers
DYN
From Benzinga
Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know
March 06, 2024
Tickers
DYN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
